Cargando…
Tumour treating fields therapy for glioblastoma: current advances and future directions
Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults and continues to portend poor survival, despite multimodal treatment using surgery and chemoradiotherapy. The addition of tumour-treating fields (TTFields)—an approach in which alternating electrical fields exert biophys...
Autores principales: | Rominiyi, Ola, Vanderlinden, Aurelie, Clenton, Susan Jane, Bridgewater, Caroline, Al-Tamimi, Yahia, Collis, Spencer James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884384/ https://www.ncbi.nlm.nih.gov/pubmed/33144698 http://dx.doi.org/10.1038/s41416-020-01136-5 |
Ejemplares similares
-
Correction: Tumour treating fields therapy for glioblastoma: current advances and future directions
por: Rominiyi, Ola, et al.
Publicado: (2021) -
DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells
por: Vanderlinden, Aurelie, et al.
Publicado: (2023) -
DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies
por: Rominiyi, Ola, et al.
Publicado: (2021) -
The ‘Ins and Outs’ of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong?
por: Rominiyi, Ola, et al.
Publicado: (2019) -
Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma
por: Carmell, Natasha, et al.
Publicado: (2021)